Dawn Carter Bir - Jul 6, 2023 Form 4 Insider Report for REATA PHARMACEUTICALS INC (RETA)

Role
Chief Commercial Officer
Signature
/s/ Tracy Herson, attorney-in-fact
Stock symbol
RETA
Transactions as of
Jul 6, 2023
Transactions value $
$0
Form type
4
Date filed
7/10/2023, 04:42 PM
Previous filing
Jun 2, 2023
Next filing
Aug 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RETA Class A common stock Award $0 +4.13K +13.36% $0.00 35K Jul 6, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares represent Restricted Stock Units granted with performance criteria (PSUs). On December 17, 2020, the reporting person was granted 4,125 PSUs. On July 6, 2023, based on certain performance criteria, the PSUs vested as to 1,031 shares, with the remainder vesting 1/12th on each subsequent 3 month anniversary, subject to continued service through each vesting date.